European Biotech Acquisition Corp. Warrant
EBACW
EBACW was delisted on the 2nd of March, 2023.
29 hedge funds and large institutions have $858K invested in European Biotech Acquisition Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.
9% less funds holding
Funds holding: 32 → 29 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
99% less capital inflows, than outflows
Capital inflows: $28K | Capital outflows: $1.87M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Clear Street
New York
|
+$23.7K |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
+$3.64K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$546 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.84M |
| 2 |
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$9K |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$5.46K |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
-$5K |
| 5 |
Woodline Partners
San Francisco,
California
|
-$5K |
EBACW Hedge Fund Activity: Q3 2022 in Review
29 of the 5,831 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q3 2022, worth a combined $858K — down 69% from $2.74M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of EBACW and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Clear Street, opening a new position worth an estimated $23.7K. The largest seller was Mangrove Partners, exiting entirely with an estimated $1.84M sold.
- 29 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q3 2022, down from 32 in Q2 2022.
- Funds reported $858K of European Biotech Acquisition Corp. Warrant stock for Q3 2022, down 69% quarter-over-quarter.
- 3 funds opened new European Biotech Acquisition Corp. Warrant positions in Q3 2022 and 6 closed out, a net change of -3 holders.
- The largest European Biotech Acquisition Corp. Warrant buyer in Q3 2022 was Clear Street, an estimated $23.7K added.
- The largest European Biotech Acquisition Corp. Warrant seller in Q3 2022 was Mangrove Partners, an estimated $1.84M sold.
Based on aggregated 13F filings for Q3 2022.